# TJ Biopharma Announces Publication of Plonmarlimab Phase 2 Results in the Journal of Hematology & Oncology

- Source: PR Newswire M&A
- Published: 2026-11-04T10:00:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/tj-biopharma-announces-publication-of-plonmarlimab-phase-2-results-in-the-journal-of-hematology--oncology-302929077.html
- Canonical: https://groundlevelnews.com/story/tj-biopharma-announces-publication-of-plonmarlimab-phase-2-results-in--557792/

Findings build on TJ Biopharma's pioneering work on GM-CSF as a therapeutic target in macrophage- and myeloid cell-driven inflammation Phase 2 results show encouraging clinical responses and glucocorticoid-sparing potential in macrophage activation syndrome HANGZHOU, China, Nov. 4, 2026...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._